Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NuProtect: Nuwiq in Previously Untreated Patients with Severe Hemophilia A
NCT01712438Phase 3Completed
- Sponsor
- Octapharma
- Start
- Feb 2013
- Primary completion
- Dec 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 17
01
Overview
A Phase 3 trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Started Feb 2013; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01712438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712438.